U.S. flag

An official website of the United States government

NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro) AND Greig cephalopolysyndactyly syndrome, severe

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jun 1, 2006
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000030896.25

Allele description [Variation Report for NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)]

NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)

Gene:
GLI3:GLI family zinc finger 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
7p14.1
Genomic location:
Preferred name:
NM_000168.6(GLI3):c.2800G>C (p.Ala934Pro)
HGVS:
  • NC_000007.14:g.41966273C>G
  • NG_008434.1:g.275748G>C
  • NM_000168.6:c.2800G>CMANE SELECT
  • NP_000159.3:p.Ala934Pro
  • NC_000007.13:g.42005871C>G
  • P10071:p.Ala934Pro
Protein change:
A934P; ALA934PRO
Links:
UniProtKB: P10071#VAR_021482; OMIM: 165240.0013; dbSNP: rs28933372
NCBI 1000 Genomes Browser:
rs28933372
Molecular consequence:
  • NM_000168.6:c.2800G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Greig cephalopolysyndactyly syndrome, severe
Identifiers:
MedGen: C4016299

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000035091OMIM
no assertion criteria provided
Pathogenic
(Jun 1, 2006)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

De novo GLI3 mutation in acrocallosal syndrome: broadening the phenotypic spectrum of GLI3 defects and overlap with murine models.

Elson E, Perveen R, Donnai D, Wall S, Black GC.

J Med Genet. 2002 Nov;39(11):804-6.

PubMed [citation]
PMID:
12414818
PMCID:
PMC1735022

What you can learn from one gene: GLI3.

Biesecker LG.

J Med Genet. 2006 Jun;43(6):465-9. Review.

PubMed [citation]
PMID:
16740916
PMCID:
PMC2564530

Details of each submission

From OMIM, SCV000035091.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

In a child with agenesis of the corpus callosum and severe retardation, both cardinal features of acrocallosal syndrome (ACLS; 200990) and rare in Greig cephalopolysyndactyly syndrome (GCPS; 175700), Elson et al. (2002) identified a heterozygous 2800G-C transversion in exon 15 of the GLI3 gene, resulting in an ala934-to-pro (A934P) mutation. At birth, he had bilateral cleft lip and palate, a large anterior fontanel extending down his forehead, overriding coronal sutures, and small ears with uplifted lobes. Pronounced hypertelorism was present and cranial MRI showed agenesis of the corpus callosum. His hands showed bilateral postaxial nubbins, a broad thumb on the right hand, and a partially duplicated left thumb. There was also partial cutaneous syndactyly bilaterally. The feet displayed bilateral duplication of the big toe and syndactyly of the other toes. At the chronologic age of 56 months he was estimated to have a mental age of 21 months. We have classified the phenotype in this patient as GCPS based on the identification of a heterozygous mutation in GLI3 as opposed to homozygous mutations in KIF7 (611254), which have been identified in patients with ACLS. Biesecker (2008) stated that patients with a phenotype consistent with GCPS and a GLI3 mutation may be diagnosed definitively as GCPS.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 11, 2022